Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Pseudouridine 5'-phosphatase pseudogene 1 (PUDPP1) is classified as a pseudogene, meaning it resembles a protein-coding gene but is generally not transcribed or translated into a functional protein[1]. As a pseudogene, it does not act as a therapeutic target, nor does it have any established role in disease, biological function, or pharmacology[1]. Multiple aliases have arisen from its sequence similarity to other hydrolase domain-containing genes, but these refer to non-functional (pseudogene) copies[1]. Note: - There is a functional paralog, Pseudouridine 5'-phosphatase (PUDP/HDHD1A), which is an enzyme that dephosphorylates pseudouridine 5'-phosphate during RNA metabolism[3][5][7]. However, PUDPP1 is specifically non-functional and not equivalent to PUDP/HDHD1A. - If seeking a true protein-coding target with related activity (pseudouridine metabolism), see Pseudouridine 5'-phosphatase (PUDP, HDHD1A) rather than PUDPP1[3][5][7]. This target is therefore not a valid drug target and is a pseudogene, not an enzyme, receptor, or other actionable protein.
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pseudouridine 5'-phosphatase pseudogene 1 (PUDPP1).